Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Rosuvastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery in people who need it and having heart disease or who are at risk of developing heart disease or ready to get the stroke. Rosuvastatin pharmacokinetics was studied in an open-label and parallel-group. The plasma concentrations of rosuvastatin and metabolites were determined by HPLC-mass spectrophotometry.
Journals Related to Rosuvastatin Pharmacokinetics:
Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Drug Metabolism & Toxicology, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Pharmacokinetics and Pharmacodynamics, Asian Journal of Pharmacodynamics and Pharmacokinetics.